肛周瘘管型克罗恩病:在临床实践中应用TOpClass分类以提供有针对性的个体化诊疗
本文介绍TOpClass分类系统在肛周瘘管型克罗恩病(PFCD)临床实践中的应用。一个国际肛周疾病临床医生小组通过专家共识,结合北美、欧洲和澳大利亚8个高容量瘘管中心的多学科团队管理经验,制定了与分类系统配套的立场声明,以指导PFCD管理,涵盖从静止期肛周疾病到需要转流性造口和/或直肠切除术的严重PFCD患者,并探讨各分类组中药物治疗优化及手术在瘘管闭合和症状管理中的应用。
要点
- TOpClass分类系统将PFCD患者分为明确组别,以聚焦与疾病特征和患者目标一致的瘘管管理。
- 国际专家共识制定了配套立场声明,指导从静止期肛周疾病到严重PFCD的管理。
- 各分类组中探讨药物治疗优化及手术在瘘管闭合和症状管理中的应用。
核心结论
- 本文概述了TOpClass系统在临床实践中的使用,旨在使临床医生能够对PFCD个体患者采取务实且以患者目标为中心的药物和手术管理方法。
研究设计与样本
- 一个国际肛周疾病临床医生小组(包括胃肠病学家、炎症性肠病外科医生和专攻PFCD的放射科医生)参与专家共识,过程参考了北美、欧洲和澳大利亚8个高容量瘘管中心的多学科团队管理经验。
主要发现
- 共识过程产生了配套分类系统的立场声明,指导PFCD管理,范围从静止期肛周疾病患者到需要转流性造口和/或直肠切除术的严重PFCD患者。
- 在各分类组中探讨了药物治疗优化以及手术在瘘管闭合和症状管理中的应用。
临床怎么用
- 本文旨在使临床医生能够对PFCD个体患者采取务实且以患者目标为中心的药物和手术管理方法。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Perianal fistulation is a challenging phenotype of Crohn's disease, with significant impact on quality of life. Historically, fistulae have been classified anatomically in relation to the sphincter complex, and management guidelines have been generalized, with lack of attention to the clinical heterogenicity seen. The recent 'TOpClass classification system' for perianal fistulizing Crohn's disease (PFCD) addresses this issue, and classifies patients into defined groups, which provide a focus for fistula management that aligns with disease characteristics and patient goals. In this article, we discuss the clinical applicability of the TOpClass model and provide direction on its use in clinical practice. METHODS: An international group of perianal clinicians participated in an expert consensus to define how the TOpClass system can be incorporated into real-life practice. This included gastroenterologists, inflammatory bowel disease surgeons, and radiologists specialized in PFCD. The process was informed by the multi-disciplinary team management of 8 high-volume fistula centres in North America, Europe, and Australia. RESULTS: The process produced position statements to accompany the classification system and guide PFCD management. The statements range from the management of patients with quiescent perianal disease to those with severe PFCD requiring diverting-ostomy and/or proctectomy. The optimization of medical therapies, as well as the use of surgery, in fistula closure and symptom management is explored across each classification group. CONCLUSION: This article provides an overview of the system's use in clinical practice. It aims to enable clinicians to have a pragmatic and patient goal-centered approach to medical and surgical management options for individual patients with PFCD.
引用
- Hanna LN, Anandabaskaran S, Iqbal N, et al. Perianal Fistulizing Crohn's Disease: Utilizing the TOpClass Classification in Clinical Practice to Provide Targeted Individualized Care. Clin Gastroenterol Hepatol. 2024. PMID: 39134293. doi:10.1016/j.cgh.2024.06.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。